Survey: Among New Platforms, MinIon Expected to Have Greatest Impact, NextSeq Most Likely Purchased | GenomeWeb

This article was originally published May 5.

NEW YORK (GenomeWeb) − Several new sequencing platforms have hit the market or are scheduled to be released this year, including Illumina's HiSeq X Ten and NextSeq 500, Oxford Nanopore's MinIon, and Qiagen's GeneReader. According to a recent survey by Mizuho Securities USA in collaboration with GenomeWeb, users believe the MinIon will have the greatest impact, though they are most likely to purchase the NextSeq 500.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.